As of Q4 2023, Grifols Sa's earnings has grown 3.77% year over year. This is 11.1 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of -7.33%. Grifols Sa's earnings in the past year totalled $226.39 million.
As of Q4 2023, Grifols Sa's revenue has grown 15.08% year over year. This is 15.28 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of -0.2%. Grifols Sa's revenue in the past year totalled $6.59 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.